<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35576218</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>19</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>5</Issue><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>A molecular view of amyotrophic lateral sclerosis through the lens of interaction network modules.</ArticleTitle><Pagination><StartPage>e0268159</StartPage><MedlinePgn>e0268159</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0268159</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0268159</ELocationID><Abstract><AbstractText Label="BACKGROUND">Despite the discovery of familial cases with mutations in Cu/Zn-superoxide dismutase (SOD1), Guanine nucleotide exchange C9orf72, TAR DNA-binding protein 43 (TARDBP) and RNA-binding protein FUS as well as a number of other genes linked to Amyotrophic Lateral Sclerosis (ALS), the etiology and molecular pathogenesis of this devastating disease is still not understood. As proteins do not act alone, conducting an analysis of ALS at the system level may provide new insights into the molecular biology of ALS and put it into relationship to other neurological diseases.</AbstractText><AbstractText Label="METHODS">A set of ALS-associated genes/proteins were collected from publicly available databases and text mining of scientific literature. We used these as seed proteins to build protein-protein interaction (PPI) networks serving as a scaffold for further analyses. From the collection of networks, a set of core modules enriched in seed proteins were identified. The molecular biology of the core modules was investigated, as were their associations to other diseases. To assess the core modules' ability to describe unknown or less well-studied ALS biology, they were queried for proteins more recently associated to ALS and not involved in the primary analysis.</AbstractText><AbstractText Label="RESULTS">We describe a set of 26 ALS core modules enriched in ALS-associated proteins. We show that these ALS core modules not only capture most of the current knowledge about ALS, but they also allow us to suggest biological interdependencies. In addition, new associations of ALS networks with other neurodegenerative diseases, e.g. Alzheimer's, Huntington's and Parkinson's disease were found. A follow-up analysis of 140 ALS-associated proteins identified since 2014 reveals a significant overrepresentation of new ALS proteins in these 26 disease modules.</AbstractText><AbstractText Label="CONCLUSIONS">Using protein-protein interaction networks offers a relevant approach for broadening the understanding of the biological context of known ALS-associated genes. Using a bottom-up approach for the analysis of protein-protein interaction networks is a useful method to avoid bias caused by over-connected proteins. Our ALS-enriched modules cover most known biological functions associated with ALS. The presence of recently identified ALS-associated proteins in the core modules highlights the potential for using these as a scaffold for identification of novel ALS disease mechanisms.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jensen</LastName><ForeName>Klaus H&#xf8;jgaard</ForeName><Initials>KH</Initials><Identifier Source="ORCID">0000-0003-3234-6068</Identifier><AffiliationInfo><Affiliation>Intomics A/S, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stalder</LastName><ForeName>Anna Katharina</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>University Hospital Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wernersson</LastName><ForeName>Rasmus</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-4417-9842</Identifier><AffiliationInfo><Affiliation>Intomics A/S, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>DTU Health Technology, Technical University of Denmark, Lyngby, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roloff-Handschin</LastName><ForeName>Tim-Christoph</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>University Hospital Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hansen</LastName><ForeName>Daniel Hvidberg</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>Intomics A/S, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Groenen</LastName><ForeName>Peter M A</ForeName><Initials>PMA</Initials><Identifier Source="ORCID">0000-0002-8172-1752</Identifier><AffiliationInfo><Affiliation>Idorsia Pharmaceuticals Ltd., Allschwil, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060066" MajorTopicYN="Y">Protein Interaction Maps</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="N">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>DHH, KHL and RWE are employees of Intomics, and RWE is a co-founder of the company. The inBio Map and inBio Know data resources used in the study are both maintained by Intomics. AS, TCRH and PG are present and former employees of Actelion Pharmaceuticals and Idorsia Pharmaceuticals. This does not alter our adherence to PLOS ONE policies on sharing data and materials</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>16</Day><Hour>13</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35576218</ArticleId><ArticleId IdType="pmc">PMC9109932</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0268159</ArticleId><ArticleId IdType="pii">PONE-D-21-38938</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Robberecht W, Philips T. The changing scene of amyotrophic lateral sclerosis. Nat Rev Neurosci. 2013;14:248&#x2013;64. doi: 10.1038/nrn3430</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3430</ArticleId><ArticleId IdType="pubmed">23463272</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Al-Chalabi A. Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat Rev Neurol. 2011;7:603&#x2013;15. doi: 10.1038/nrneurol.2011.150</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.150</ArticleId><ArticleId IdType="pubmed">21989245</ArticleId></ArticleIdList></Reference><Reference><Citation>National Library of Medicine. ghr.nlm.nih.gov. Accessed 1 Jun 2020.</Citation></Reference><Reference><Citation>Morgan S, Shoai M, Fratta P, Sidle K, Orrell R, Sweeney MG, et al.. Investigation of next-generation sequencing technologies as a diagnostic tool for amyotrophic lateral sclerosis. Neurobiol Aging. 2015;36:1600.e5&#x2013;1600.e8. doi: 10.1016/j.neurobiolaging.2014.12.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.12.017</ArticleId><ArticleId IdType="pubmed">25588603</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R, Chi&#xf2; A, Traynor BJ. Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet Neurol. 2018;17:94&#x2013;102. doi: 10.1016/S1474-4422(17)30401-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30401-5</ArticleId><ArticleId IdType="pmc">PMC5901717</ArticleId><ArticleId IdType="pubmed">29154141</ArticleId></ArticleIdList></Reference><Reference><Citation>Jellinger KA, Korczyn AD. Are dementia with Lewy bodies and Parkinson&#x2019;s disease dementia the same disease? Bmc Med. 2018;16:34,34. doi: 10.1186/s12916-018-1016-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-018-1016-8</ArticleId><ArticleId IdType="pmc">PMC5840831</ArticleId><ArticleId IdType="pubmed">29510692</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong MJ, Abrahams S, Goldstein LH, Woolley S, Mclaughlin P, Snowden J, et al.. Amyotrophic lateral sclerosis&#x2014;frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria. Amyotroph Lateral Scler Front Degener. 2017;18:153&#x2013;74. doi: 10.1080/21678421.2016.1267768</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1267768</ArticleId><ArticleId IdType="pmc">PMC7409990</ArticleId><ArticleId IdType="pubmed">28054827</ArticleId></ArticleIdList></Reference><Reference><Citation>Yedavalli VS, Patil A, Shah P. Amyotrophic Lateral Sclerosis and its Mimics/Variants: A Comprehensive Review. J Clin Imaging Sci. 2018;8:53,53. doi: 10.4103/jcis.JCIS_40_18</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jcis.JCIS_40_18</ArticleId><ArticleId IdType="pmc">PMC6302559</ArticleId><ArticleId IdType="pubmed">30652056</ArticleId></ArticleIdList></Reference><Reference><Citation>Vidal M, Cusick ME, Barab&#xe1;si A-L. Interactome Networks and Human Disease. Cell. 2011;144:986&#x2013;98. doi: 10.1016/j.cell.2011.02.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2011.02.016</ArticleId><ArticleId IdType="pmc">PMC3102045</ArticleId><ArticleId IdType="pubmed">21414488</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanehisa M, Sato Y, Furumichi M, Morishima K, Tanabe M. New approach for understanding genome variations in KEGG. Nucleic Acids Res. 2019;47:D590&#x2013;5. doi: 10.1093/nar/gky962</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky962</ArticleId><ArticleId IdType="pmc">PMC6324070</ArticleId><ArticleId IdType="pubmed">30321428</ArticleId></ArticleIdList></Reference><Reference><Citation>Slenter DN, Kutmon M, Hanspers K, Riutta A, Windsor J, Nunes N, et al.. WikiPathways: a multifaceted pathway database bridging metabolomics to other omics research. Nucleic Acids Res. 2018;46:D661&#x2013;7. doi: 10.1093/nar/gkx1064</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx1064</ArticleId><ArticleId IdType="pmc">PMC5753270</ArticleId><ArticleId IdType="pubmed">29136241</ArticleId></ArticleIdList></Reference><Reference><Citation>Croft D, Mundo AF, Haw R, Milacic M, Weiser J, Wu G, et al.. The Reactome pathway knowledgebase. Nucleic Acids Res. 2014;42:D472&#x2013;7. doi: 10.1093/nar/gkt1102</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkt1102</ArticleId><ArticleId IdType="pmc">PMC3965010</ArticleId><ArticleId IdType="pubmed">24243840</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T, Wernersson R, Hansen RB, Horn H, Mercer J, Slodkowicz G, et al.. A scored human protein&#x2013;protein interaction network to catalyze genomic interpretation. Nat Methods. 2017;14:61&#x2013;4. doi: 10.1038/nmeth.4083</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.4083</ArticleId><ArticleId IdType="pmc">PMC5839635</ArticleId><ArticleId IdType="pubmed">27892958</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmati S, Abovsky M, Pastrello C, Jurisica I. pathDIP: an annotated resource for known and predicted human gene-pathway associations and pathway enrichment analysis. Nucleic Acids Res. 2017;45:D419&#x2013;26. doi: 10.1093/nar/gkw1082</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw1082</ArticleId><ArticleId IdType="pmc">PMC5210562</ArticleId><ArticleId IdType="pubmed">27899558</ArticleId></ArticleIdList></Reference><Reference><Citation>Mellacheruvu D, Wright Z, Couzens AL, Lambert J-P, St-Denis NA, Li T, et al.. The CRAPome: a contaminant repository for affinity purification&#x2013;mass spectrometry data. Nat Methods. 2013;10:730&#x2013;6. doi: 10.1038/nmeth.2557</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2557</ArticleId><ArticleId IdType="pmc">PMC3773500</ArticleId><ArticleId IdType="pubmed">23921808</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong H, Mason SP, Barab&#xe1;si A-L, Oltvai ZN. Lethality and centrality in protein networks. Nature. 2001;411:41&#x2013;2. doi: 10.1038/35075138</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35075138</ArticleId><ArticleId IdType="pubmed">11333967</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Y, Kuo S-W, Chen L, Heckman CJ, Jiang MC. The essential and downstream common proteins of amyotrophic lateral sclerosis: A protein-protein interaction network analysis. PLoS One. 2017;12:e0172246. doi: 10.1371/journal.pone.0172246</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0172246</ArticleId><ArticleId IdType="pmc">PMC5345759</ArticleId><ArticleId IdType="pubmed">28282387</ArticleId></ArticleIdList></Reference><Reference><Citation>Bader GD, Hogue CW. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics. 2003;4:2. doi: 10.1186/1471-2105-4-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-4-2</ArticleId><ArticleId IdType="pmc">PMC149346</ArticleId><ArticleId IdType="pubmed">12525261</ArticleId></ArticleIdList></Reference><Reference><Citation>Nepusz T, Yu H, Paccanaro A. Detecting overlapping protein complexes in protein-protein interaction networks. Nat Methods. 2012;9:471&#x2013;2. doi: 10.1038/nmeth.1938</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.1938</ArticleId><ArticleId IdType="pmc">PMC3543700</ArticleId><ArticleId IdType="pubmed">22426491</ArticleId></ArticleIdList></Reference><Reference><Citation>Apweiler R. UniProt: the Universal Protein knowledgebase. Nucleic Acids Res. 2004;32:115D &#x2013; 119. doi: 10.1093/nar/gkh131</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkh131</ArticleId><ArticleId IdType="pmc">PMC308865</ArticleId><ArticleId IdType="pubmed">14681372</ArticleId></ArticleIdList></Reference><Reference><Citation>Wroe R, Wai-Ling Butler A, Andersen PM, Powell JF, Al-Chalabi A. ALSOD: The Amyotrophic Lateral Sclerosis Online Database. Amyotroph Lateral Scler. 2008;9:249&#x2013;50. doi: 10.1080/17482960802146106</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960802146106</ArticleId><ArticleId IdType="pubmed">18608099</ArticleId></ArticleIdList></Reference><Reference><Citation>ALSgene. http://www.alsgene.org/top_results. Accessed 2 May 2014.</Citation></Reference><Reference><Citation>Wall DP, Pivovarov R, Tong M, Jung J-Y, Fusaro VA, DeLuca TF, et al.. Genotator: A disease-agnostic tool for genetic annotation of disease. BMC Med Genomics. 2010;3:50. doi: 10.1186/1755-8794-3-50</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1755-8794-3-50</ArticleId><ArticleId IdType="pmc">PMC2990725</ArticleId><ArticleId IdType="pubmed">21034472</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker KG, Barnes KC, Bright TJ, Wang SA. The Genetic Association Database. Nat Genet. 2004;36:431&#x2013;2. doi: 10.1038/ng0504-431</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng0504-431</ArticleId><ArticleId IdType="pubmed">15118671</ArticleId></ArticleIdList></Reference><Reference><Citation>GAD full data set. https://geneticassociationdb.nih.gov/data.zip. Accessed 2 May 2014.</Citation></Reference><Reference><Citation>Yu W, Yesupriya A, Wulf A, Hindorff LA, Dowling N, Khoury MJ, et al.. GWAS Integrator: a bioinformatics tool to explore human genetic associations reported in published genome-wide association studies. Eur J Hum Genet. 2011;19:1095&#x2013;9. doi: 10.1038/ejhg.2011.91</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ejhg.2011.91</ArticleId><ArticleId IdType="pmc">PMC3190251</ArticleId><ArticleId IdType="pubmed">21610748</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu W, Wulf A, Liu T, Khoury MJ, Gwinn M. Gene Prospector: An evidence gateway for evaluating potential susceptibility genes and interacting risk factors for human diseases. BMC Bioinformatics. 2008;9:528. doi: 10.1186/1471-2105-9-528</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-9-528</ArticleId><ArticleId IdType="pmc">PMC2613935</ArticleId><ArticleId IdType="pubmed">19063745</ArticleId></ArticleIdList></Reference><Reference><Citation>inBio Know&#x2014;text minining site. https://inbio-discover.com/know.html. Accessed 20 Jul 2017.</Citation></Reference><Reference><Citation>Shannon P. Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks. Genome Res. 2003;13:2498&#x2013;504. doi: 10.1101/gr.1239303</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.1239303</ArticleId><ArticleId IdType="pmc">PMC403769</ArticleId><ArticleId IdType="pubmed">14597658</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al.. Gene Ontology: tool for the unification of biology. Nat Genet. 2000;25:25&#x2013;9. doi: 10.1038/75556</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/75556</ArticleId><ArticleId IdType="pmc">PMC3037419</ArticleId><ArticleId IdType="pubmed">10802651</ArticleId></ArticleIdList></Reference><Reference><Citation>Carbon S. Expansion of the Gene Ontology knowledgebase and resources. Nucleic Acids Res. 2017;45:D331&#x2013;8. doi: 10.1093/nar/gkw1108</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw1108</ArticleId><ArticleId IdType="pmc">PMC5210579</ArticleId><ArticleId IdType="pubmed">27899567</ArticleId></ArticleIdList></Reference><Reference><Citation>Schriml LM, Arze C, Nadendla S, Chang Y-WW, Mazaitis M, Felix V, et al.. Disease Ontology: a backbone for disease semantic integration. Nucleic Acids Res. 2012;40:D940&#x2013;6. doi: 10.1093/nar/gkr972</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkr972</ArticleId><ArticleId IdType="pmc">PMC3245088</ArticleId><ArticleId IdType="pubmed">22080554</ArticleId></ArticleIdList></Reference><Reference><Citation>Kibbe WA, Arze C, Felix V, Mitraka E, Bolton E, Fu G, et al.. Disease Ontology 2015 update: an expanded and updated database of human diseases for linking biomedical knowledge through disease data. Nucleic Acids Res. 2015;43:D1071&#x2013;8. doi: 10.1093/nar/gku1011</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gku1011</ArticleId><ArticleId IdType="pmc">PMC4383880</ArticleId><ArticleId IdType="pubmed">25348409</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz-Ortiz ME, Chen-Plotkin AS. Omics in Neurodegenerative Disease: Hope or Hype? Trends Genet. 2020;36:152&#x2013;9. doi: 10.1016/j.tig.2019.12.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2019.12.002</ArticleId><ArticleId IdType="pmc">PMC7065657</ArticleId><ArticleId IdType="pubmed">31932096</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al.. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62,59&#x2013;62. doi: 10.1038/362059a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Harraz MM, Marden JJ, Zhou W, Zhang Y, Williams A, Sharov VS, et al.. SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model. J Clin Invest. 2008;118. doi: 10.1172/JCI34060</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI34060</ArticleId><ArticleId IdType="pmc">PMC2213375</ArticleId><ArticleId IdType="pubmed">18219391</ArticleId></ArticleIdList></Reference><Reference><Citation>Seetharaman S V, Prudencio M, Karch C, Holloway SP, Borchelt DR, Hart PJ. Immature copper-zinc superoxide dismutase and familial amyotrophic lateral sclerosis. Exp Biol Med. 2009;234:1140&#x2013;1154,1140&#x2013;1154. doi: 10.3181/0903-MR-104</Citation><ArticleIdList><ArticleId IdType="doi">10.3181/0903-MR-104</ArticleId><ArticleId IdType="pmc">PMC2850267</ArticleId><ArticleId IdType="pubmed">19596823</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalmar B, Lu C-H, Greensmith L. The role of heat shock proteins in Amyotrophic Lateral Sclerosis: The therapeutic potential of Arimoclomol. Pharmacol Ther. 2014;141:40&#x2013;54. doi: 10.1016/j.pharmthera.2013.08.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2013.08.003</ArticleId><ArticleId IdType="pubmed">23978556</ArticleId></ArticleIdList></Reference><Reference><Citation>Capponi S, Geuens T, Geroldi A, Origone P, Verdiani S, Cichero E, et al.. Molecular Chaperones in the Pathogenesis of Amyotrophic Lateral Sclerosis: The Role of HSPB1. Hum Mutat. 2016;37:1202&#x2013;1208,1202&#x2013;1208. doi: 10.1002/humu.23062</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.23062</ArticleId><ArticleId IdType="pmc">PMC5108433</ArticleId><ArticleId IdType="pubmed">27492805</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Martin E, Gonzales V, Borchelt DR, Lee MK. Differential regulation of small heat shock proteins in transgenic mouse models of neurodegenerative diseases. Neurobiol Aging. 2008;29:586&#x2013;597,586&#x2013;597. doi: 10.1016/j.neurobiolaging.2006.11.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2006.11.009</ArticleId><ArticleId IdType="pmc">PMC2292815</ArticleId><ArticleId IdType="pubmed">17316906</ArticleId></ArticleIdList></Reference><Reference><Citation>Arrigo A-P. Mammalian HspB1 (Hsp27) is a molecular sensor linked to the physiology and environment of the cell. Cell Stress Chaperones. 2017;22:517&#x2013;29. doi: 10.1007/s12192-017-0765-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12192-017-0765-1</ArticleId><ArticleId IdType="pmc">PMC5465029</ArticleId><ArticleId IdType="pubmed">28144778</ArticleId></ArticleIdList></Reference><Reference><Citation>Weeks SD, Muranova LK, Heirbaut M, Beelen S, Strelkov S V., Gusev NB. Characterization of human small heat shock protein HSPB1 &#x3b1;-crystallin domain localized mutants associated with hereditary motor neuron diseases. Sci Rep. 2018;8:688. doi: 10.1038/s41598-017-18874-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-18874-x</ArticleId><ArticleId IdType="pmc">PMC5766566</ArticleId><ArticleId IdType="pubmed">29330367</ArticleId></ArticleIdList></Reference><Reference><Citation>Tracey TJ, Steyn FJ, Wolvetang EJ, Ngo ST. Neuronal Lipid Metabolism: Multiple Pathways Driving Functional Outcomes in Health and Disease. Front Mol Neurosci. 2018;11. doi: 10.3389/fnmol.2018.00011</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00011</ArticleId><ArticleId IdType="pmc">PMC5787076</ArticleId><ArticleId IdType="pubmed">29410613</ArticleId></ArticleIdList></Reference><Reference><Citation>Palamiuc L, Schlagowski A, Ngo ST, Vernay A, Dirrig&#x2010;Grosch S, Henriques A, et al.. A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis. EMBO Mol Med. 2015;7:526&#x2013;46. doi: 10.15252/emmm.201404433</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201404433</ArticleId><ArticleId IdType="pmc">PMC4492815</ArticleId><ArticleId IdType="pubmed">25820275</ArticleId></ArticleIdList></Reference><Reference><Citation>Henriques A, Huebecker M, Blasco H, Keime C, Andres CR, Corcia P, et al.. Inhibition of &#x3b2;-Glucocerebrosidase Activity Preserves Motor Unit Integrity in a Mouse Model of Amyotrophic Lateral Sclerosis. Sci Rep. 2017;7:5235. doi: 10.1038/s41598-017-05313-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-05313-0</ArticleId><ArticleId IdType="pmc">PMC5507914</ArticleId><ArticleId IdType="pubmed">28701774</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebert D, Haller RG, Walton ME. Energy Contribution of Octanoate to Intact Rat Brain Metabolism Measured by 13 C Nuclear Magnetic Resonance Spectroscopy. J Neurosci. 2003;23:5928&#x2013;35. doi: 10.1523/JNEUROSCI.23-13-05928.2003</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.23-13-05928.2003</ArticleId><ArticleId IdType="pmc">PMC6741266</ArticleId><ArticleId IdType="pubmed">12843297</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Oudart H, Rene F, de Aguilar J-LG, Loeffler J-P. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: Benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci. 2004;101:11159&#x2013;64. doi: 10.1073/pnas.0402026101</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0402026101</ArticleId><ArticleId IdType="pmc">PMC503756</ArticleId><ArticleId IdType="pubmed">15263088</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattson MP, Cutler RG, Camandola S. Energy Intake and Amyotrophic Lateral Sclerosis. NeuroMolecular Med. 2007;9:17&#x2013;20. doi: 10.1385/nmm:9:1:17</Citation><ArticleIdList><ArticleId IdType="doi">10.1385/nmm:9:1:17</ArticleId><ArticleId IdType="pubmed">17114821</ArticleId></ArticleIdList></Reference><Reference><Citation>Wills A-M, Hubbard J, Macklin EA, Glass J, Tandan R, Simpson EP, et al.. Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet. 2014;383:2065&#x2013;72. doi: 10.1016/S0140-6736(14)60222-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)60222-1</ArticleId><ArticleId IdType="pmc">PMC4176708</ArticleId><ArticleId IdType="pubmed">24582471</ArticleId></ArticleIdList></Reference><Reference><Citation>Verghese PB, Castellano JM, Holtzman DM. Apolipoprotein E in Alzheimer&#x2019;s disease and other neurological disorders. Lancet Neurol. 2011;10:241&#x2013;52. doi: 10.1016/S1474-4422(10)70325-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70325-2</ArticleId><ArticleId IdType="pmc">PMC3132088</ArticleId><ArticleId IdType="pubmed">21349439</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou M, Lagier-Tourenne C, Hutt KR, Huelga SC, Moran J, Liang TY, et al.. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat Neurosci. 2011;14:459&#x2013;68. doi: 10.1038/nn.2779</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2779</ArticleId><ArticleId IdType="pmc">PMC3094729</ArticleId><ArticleId IdType="pubmed">21358643</ArticleId></ArticleIdList></Reference><Reference><Citation>Gascon E, Gao F-B. The Emerging Roles of MicroRNAs in the Pathogenesis of Frontotemporal Dementia&#x2013;Amyotrophic Lateral Sclerosis (FTD-ALS) Spectrum Disorders. J Neurogenet. 2014;28:30&#x2013;40. doi: 10.3109/01677063.2013.876021</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/01677063.2013.876021</ArticleId><ArticleId IdType="pmc">PMC4199862</ArticleId><ArticleId IdType="pubmed">24506814</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberstadt M, Cla&#xdf;en J, Arendt T, Holzer M. TDP-43 and Cytoskeletal Proteins in ALS. Mol Neurobiol. 2018;55:3143&#x2013;51. doi: 10.1007/s12035-017-0543-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-017-0543-1</ArticleId><ArticleId IdType="pubmed">28466273</ArticleId></ArticleIdList></Reference><Reference><Citation>Iglesias V, Paladin L, Juan-Blanco T, Pallar&#xe8;s I, Aloy P, Tosatto SCE, et al.. In silico Characterization of Human Prion-Like Proteins: Beyond Neurological Diseases. Front Physiol. 2019;10. doi: 10.3389/fphys.2019.00010</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2019.00010</ArticleId><ArticleId IdType="pmc">PMC6445884</ArticleId><ArticleId IdType="pubmed">30971948</ArticleId></ArticleIdList></Reference><Reference><Citation>McAlary L, Plotkin SS, Yerbury JJ, Cashman NR. Prion-Like Propagation of Protein Misfolding and Aggregation in Amyotrophic Lateral Sclerosis. Front Mol Neurosci. 2019;12. doi: 10.3389/fnmol.2019.00012</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00012</ArticleId><ArticleId IdType="pmc">PMC6838634</ArticleId><ArticleId IdType="pubmed">31736708</ArticleId></ArticleIdList></Reference><Reference><Citation>Porta S, Xu Y, Restrepo CR, Kwong LK, Zhang B, Brown HJ, et al.. Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo. Nat Commun. 2018;9. doi: 10.1038/s41467-017-01881-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-01881-x</ArticleId><ArticleId IdType="pmc">PMC6181940</ArticleId><ArticleId IdType="pubmed">30310141</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R, Isaacs AM. C9orf72-mediated ALS and FTD: multiple pathways to disease. Nat Rev Neurol. 2018;14:544&#x2013;58. doi: 10.1038/s41582-018-0047-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0047-2</ArticleId><ArticleId IdType="pmc">PMC6417666</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty MJ. Driven to decay: Excitability and synaptic abnormalities in amyotrophic lateral sclerosis. Brain Res Bull. 2018;140:318&#x2013;33. doi: 10.1016/j.brainresbull.2018.05.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2018.05.023</ArticleId><ArticleId IdType="pubmed">29870780</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster CP, Smith EF, Shaw PJ, De Vos KJ. Protein Homeostasis in Amyotrophic Lateral Sclerosis: Therapeutic Opportunities? Front Mol Neurosci. 2017;10. doi: 10.3389/fnmol.2017.00010</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00010</ArticleId><ArticleId IdType="pmc">PMC5411428</ArticleId><ArticleId IdType="pubmed">28512398</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorn T, Kornherr J, Parrotta EI, Zawada D, Ayetey H, Santamaria G, et al.. Interplay of cell&#x2013;cell contacts and RhoA/ MRTF &#x2010;A signaling regulates cardiomyocyte identity. EMBO J. 2018;37. doi: 10.15252/embj.201798133</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201798133</ArticleId><ArticleId IdType="pmc">PMC6003642</ArticleId><ArticleId IdType="pubmed">29764980</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, Taylor JP. Lost in Transportation: Nucleocytoplasmic Transport Defects in ALS and Other Neurodegenerative Diseases. Neuron. 2017;96:285&#x2013;97. doi: 10.1016/j.neuron.2017.07.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.07.029</ArticleId><ArticleId IdType="pmc">PMC5678982</ArticleId><ArticleId IdType="pubmed">29024655</ArticleId></ArticleIdList></Reference><Reference><Citation>Soo KY, Halloran M, Sundaramoorthy V, Parakh S, Toth RP, Southam KA, et al.. Rab1-dependent ER&#x2013;Golgi transport dysfunction is a common pathogenic mechanism in SOD1, TDP-43 and FUS-associated ALS. Acta Neuropathol. 2015;130:679&#x2013;97. doi: 10.1007/s00401-015-1468-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1468-2</ArticleId><ArticleId IdType="pubmed">26298469</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vos KJ, Hafezparast M. Neurobiology of axonal transport defects in motor neuron diseases: Opportunities for translational research? Neurobiol Dis. 2017;105:283&#x2013;99. doi: 10.1016/j.nbd.2017.02.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2017.02.004</ArticleId><ArticleId IdType="pmc">PMC5536153</ArticleId><ArticleId IdType="pubmed">28235672</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodge JC, Treleaven CM, Pacheco J, Cooper S, Bao C, Abraham M, et al.. Glycosphingolipids are modulators of disease pathogenesis in amyotrophic lateral sclerosis. Proc Natl Acad Sci. 2015;112:8100&#x2013;5. doi: 10.1073/pnas.1508767112</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1508767112</ArticleId><ArticleId IdType="pmc">PMC4491749</ArticleId><ArticleId IdType="pubmed">26056266</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Peng Z, Ren G, Wang G. The different roles of selective autophagic protein degradation in mammalian cells. Oncotarget. 2015;6:37098&#x2013;116. doi: 10.18632/oncotarget.5776</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.5776</ArticleId><ArticleId IdType="pmc">PMC4741918</ArticleId><ArticleId IdType="pubmed">26415220</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma A. Protein aggregates and regional disease spread in ALS is reminiscent of prion-like pathogenesis. Neurol India. 2013;61:107&#x2013;10. doi: 10.4103/0028-3886.111109</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0028-3886.111109</ArticleId><ArticleId IdType="pubmed">23644307</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubin RA, Wawrousek EF, Piatigorsky J. Expression of the murine alpha B-crystallin gene is not restricted to the lens. Mol Cell Biol. 1989;9:1083 LP&#x2013; 1091. doi: 10.1128/MCB.9.3.1083</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.9.3.1083</ArticleId><ArticleId IdType="pmc">PMC362698</ArticleId><ArticleId IdType="pubmed">2725488</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito H, Kamei K, Iwamoto I, Inaguma Y, Tsuzuki M, Kishikawa M, et al.. Hsp27 suppresses the formation of inclusion bodies induced by expression of R120G&#x3b1;B-crystallin, a cause of desmin-related myopathy. Cell Mol Life Sci C. 2003;60:1217&#x2013;23. doi: 10.1007/s00018-003-3024-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-003-3024-9</ArticleId><ArticleId IdType="pubmed">12861387</ArticleId></ArticleIdList></Reference><Reference><Citation>Brady JP, Garland DL, Green DE, Tamm ER, Giblin FJ, Wawrousek EF. &#x3b1;B-Crystallin in Lens Development and Muscle Integrity: A Gene Knockout Approach. Invest Ophthalmol Vis Sci. 2001;42:2924&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">11687538</ArticleId></ArticleIdList></Reference><Reference><Citation>Iaconelli J, Xuan L, Karmacharya R. HDAC6 Modulates Signaling Pathways Relevant to Synaptic Biology and Neuronal Differentiation in Human Stem-Cell-Derived Neurons. Int J Mol Sci. 2019;20:1605. doi: 10.3390/ijms20071605</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20071605</ArticleId><ArticleId IdType="pmc">PMC6480207</ArticleId><ArticleId IdType="pubmed">30935091</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W, Van Den Bosch L. Therapeutic potential of HDAC6 in amyotrophic lateral sclerosis. Cell Stress. 2018;2:14&#x2013;6. doi: 10.15698/cst2018.01.120</Citation><ArticleIdList><ArticleId IdType="doi">10.15698/cst2018.01.120</ArticleId><ArticleId IdType="pmc">PMC6551843</ArticleId><ArticleId IdType="pubmed">31225447</ArticleId></ArticleIdList></Reference><Reference><Citation>Aulas A, Vande Velde C. Alterations in stress granule dynamics driven by TDP-43 and FUS: a link to pathological inclusions in ALS? Front Cell Neurosci. 2015;9:423. doi: 10.3389/fncel.2015.00423</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00423</ArticleId><ArticleId IdType="pmc">PMC4615823</ArticleId><ArticleId IdType="pubmed">26557057</ArticleId></ArticleIdList></Reference><Reference><Citation>de Boer EMJ, Orie VK, Williams T, Baker MR, De Oliveira HM, Polvikoski T, et al.. TDP-43 proteinopathies: a new wave of neurodegenerative diseases. J Neurol Neurosurg Psychiatry. 2020;:jnnp-2020-322983. doi: 10.1136/jnnp-2020-322983</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-322983</ArticleId><ArticleId IdType="pmc">PMC7803890</ArticleId><ArticleId IdType="pubmed">33177049</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y, Kim JW. Toxic Encephalopathy. Saf Health Work. 2012;3:243&#x2013;56. doi: 10.5491/SHAW.2012.3.4.243</Citation><ArticleIdList><ArticleId IdType="doi">10.5491/SHAW.2012.3.4.243</ArticleId><ArticleId IdType="pmc">PMC3521923</ArticleId><ArticleId IdType="pubmed">23251840</ArticleId></ArticleIdList></Reference><Reference><Citation>MalaCards. https://www.malacards.org. Accessed 1 Jul 2020.</Citation></Reference><Reference><Citation>Su F-C, Goutman SA, Chernyak S, Mukherjee B, Callaghan BC, Batterman S, et al.. Association of Environmental Toxins With Amyotrophic Lateral Sclerosis. JAMA Neurol. 2016;73:803. doi: 10.1001/jamaneurol.2016.0594</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2016.0594</ArticleId><ArticleId IdType="pmc">PMC5032145</ArticleId><ArticleId IdType="pubmed">27159543</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>